UNSPSC 51284035: Minocycline hydrochloride

This classification denotes a tetracycline antibiotic with the molecular formula C23H27N3O7.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0020414E5U, chemically known as 7-dimethylamino-6-demethyl-6-deoxytetracycline, hcl but more generally known as minocycline hydrochloride, which bears US NIH Compound Identifier 5281093. European Medicines Agency schedules Minocycline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03304MIG.

UNSPSC 51284035 Minocycline hydrochloride is a Commodity code for a specific tetracycline antibiotic formulation, yet recent state and local procurement activity under this code shows little pharmaceutical purchasing aligned with minocycline itself. Instead, issuing bodies are tagging unrelated pharmaceutical and medical-supply procurements — including antimicrobial tablets (doxycycline and ciprofloxacin), naloxone opioid-reversal kits, and drug deactivation systems — to this code. The scope mismatch suggests either inconsistent coding discipline in state and local procurement systems or a data artifact; the code's nominal scope (minocycline hydrochloride tablets or suspension) does not reflect what is actually being bought under it in visible recent opportunities.

State and local health agencies and counties are the primary issuing bodies. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse cooperative purchasing vehicle to Chartwell Rx LLC on August 28, 2026, for doxycycline hyclate and ciprofloxacin hydrochloride tablets totaling $2,999,999.11 over a three-year term including renewals. Seminole County, Florida posted an IFB on June 30, 2026, seeking 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries to its community health building in Sanford, Florida; the bid deadline was July 26, 2023, suggesting the opportunity may have closed. Activity concentrates in Florida and Illinois, though the small sample and coding misalignment limit confidence in broader geographic or sectoral patterns. Firms pursuing this code should verify that state and local procurement offices are actually issuing under it for minocycline or related tetracycline antibiotics, rather than assuming the recent tagged opportunities reflect the code's intended scope.